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ABSTRACT
Patient-derived specimens are an invaluable resource to investigate
tumor biology. However, in vivo studies on primary cultures are often
limited by the small amount of material available, while conventional
in vitro systems might alter the features and behavior that characterize
cancer cells. We present our data obtained on primary dedifferentiated
liposarcoma cells cultured in a 3D scaffold-based system and injected
into a zebrafish model. Primary cells were characterized in vitro for their
morphological features, sensitivity to drugs and biomarker expression,
and in vivo for their engraftment and invasiveness abilities. The 3D
culture showed a higher enrichment in cancer cells than the standard
monolayer culture and a better preservation of liposarcoma-associated
markers. We also successfully grafted primary cells into zebrafish,
showing their local migratory and invasive abilities. Our work provides
proof of concept of the ability of 3D cultures to maintain the original
phenotype of ex vivo cells, and highlights the potential of the zebrafish
model to provide a versatile in vivo system for studies with limited
biological material. Such models could be used in translational research
studies for biomolecular analyses, drug screenings and tumor
aggressiveness assays.
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INTRODUCTION
Tissue specimens from patients provide the ideal experimental
material to study the heterogeneous biology and behavior of cancer
cells. Conversely, immortalized cell lines undergo a phenotypic,
epigenetic and sometimes genetic drift from the early matching tumor,
maintaining only part of their pathologically relevant properties
(Williams et al., 2013). However, the number of research experiments
that can be carried out on primary tissue specimens is often extremely
limited due to the often small amount of material available from these
samples. The establishment of in vivo animal models required to
evaluate and validate a number of cancer cell phenotypes is thus not
always feasible. In addition, many of the features that characterize
cancer cells may be lost in the conventional systems used in in vitro
studies up to now, limiting our understanding of disease progression
and our potential to screen for effective drugs (Allen and Jones, 2011;
Dvorak et al., 2011; Hanahan and Weinberg, 2011). Biomimetic,
tridimensional (3D) models represent an optimal tool to provide a
tissue-like context for cell cultures. These systems mimic the
composition and signaling cues of the tumor extracellular matrix,
which may influence the genotype, phenotype and behavior of cancer
cells (Lamhamedi-Cherradi et al., 2014; Yamada et al., 2007). For this
reason the use of 3D culture has been extensively explored for the
study of cancer cell lines (Florczyk et al., 2013; Hirt et al., 2015;
Fitzgerald et al., 2015) and has been reported also for patient-derived
primary material (Reagan et al., 2014; Lv et al., 2016). These culture
systems, demonstrating greater fidelity to the in vivo scenario, emerged
as valuable approaches to investigate the tumor cell biology and to
screen new drugs. Despite their advantages, i.e. the possibility of
finely controlling culture conditions and of optimizing scaffold
structure and composition, these approaches cannot reproduce the
complex environment of an in vivo model. Conversely, the zebrafish
could provide a rapid and effective in vivo means of screening for
functional cancer-related phenotypes, and cell migratory and invasive
abilities starting from limited primarymaterial. The zebrafish system is
currently being evaluated in relation to its potential implications for
personalized therapy, and studies on human cancer xenografts in this
model are steadily increasing (Barriuso et al., 2015). However, there is
still relatively little information in the literature on the engraftment of
near-patient material (or patient-derived xenografts, PDX). Some
studies have reported the successful engraftment of near-patient
specimens, i.e. cell suspensions or tissue fragments, in zebrafish,
especially in its embryonic stage. This includes specimens of healthy
and fibrotic tissue (Benyumov et al., 2012; Orlova et al., 2014) as well
as malignant tissue from various sources such as gastrointestinal
tumors (Marques et al., 2009), prostate cancer (Bansal et al., 2014),
glioblastoma multiforme (Rampazzo et al., 2013) and leukemia
(Bentley et al., 2015; Pruvot et al., 2011). In the field of cancer
research, rare tumors represent a heterogeneous subset of
malignancies whose natural biology, treatment and potential
clinical outcome may differ significantly (Raghavan et al., 2012).
Their heterogeneity and low incidence also hamper near-patient
research studies. Liposarcoma is the most common soft-tissue
sarcoma, accounting for up to 15% of all cases of adult sarcoma
(Crago and Singer, 2011). It is divided into three different subtypes
on the basis of histological characteristics: well differentiated/
dedifferentiated (WDLPS/DDLPS), myxoid (MLPS) and
pleomorphic (PLS) (Clark et al., 2005; Conyers et al., 2011; DeiReceived 19 October 2016; Accepted 23 November 2016
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Tos, 2000; Dodd, 2012; Fletcher, 2014). Complete surgical resection
represents the standard medical care for patients with localized
disease, while chemotherapy and radiotherapy for metastatic or
unresectable tumors is preferred but still much debated. In recent
years, significant advances have been made in our understanding of
the molecular and cellular biology of WDLP and DDLP, opening up
new avenues of research for the diagnosis and treatment of these
patients. Chromosomal amplification of the 12q13–15 region,
including the MDM2 and CDK4 genes, is the hallmark genetic
change in these diseases. Amplification of MDM2 occurs in almost
all DDLPS cases and detection by fluorescence in situ hybridization
is widely used as a diagnostic tool (Hoffman et al., 2011; Hostein
et al., 2004; Rieker et al., 2010). However, the extremely variable
biology of these tumors has limited the identification of predictive
and prognostic biomarkers, and also hindered the collection of
accurate data on DDLPS response to chemotherapy (Italiano et al.,
2012; Tseng et al., 2013). Doxorubicin and ifosfamide represent the
standard chemotherapy agents for the treatment of advanced soft
tissue sarcoma, objective response rates (ORRs) ranging from
15-30% when the drugs are used singly and from 20-40% when
they are administered in combination, with no difference in overall
survival (Edmonson et al., 1993). Recently, trabectedin was approved
for the treatment of advanced soft tissue sarcoma after it was shown to
reduce the risk of disease progression or death by 45% compared to
dacarbazine, with an ORR of 9.9% (Demetri et al., 2016).
We used 3D collagen-based scaffolds and a zebrafish model to
study the invasive ability, chemotherapy sensitivity and biomarker
expression of near-patient cells derived from a dedifferentiated
liposarcoma lesion, and to evaluate the translational potential of
these experimental models.
RESULTS
Establishment of the ex vivo 3D tumor model
The scaffolds displayed an average porosity of 85%, with a mean
pore size of 24.674×103 (±1.332) µm2 and a total void space of
48.901×103 (±0.218) μm3 (Fig. 1A). Hematoxylin and eosin (HE)
staining of the surgical specimen showed a tumor with high
cellularity and mostly spindle-shaped cells arranged in storiform
patterns. Focal transition into well differentiated atypical adipose
tissue was present. The primary culture obtained from the surgical
material was stable for 4-5 subculture passages in both the
collagen-based scaffolds and monolayer cultures. The biomimetic
properties of the collagen scaffold induced primary cells to
strongly interact with the surrounding matrix. After 3 weeks of
culture the scaffolds appeared completely remodeled, showing
increased density and altered geometry: the macroscopic
dimensions changed from 1×9 mm to about 3×3.5 mm and the
matrix appeared markedly denser with a reorganization of
the collagen fibers (Fig. 1B). Although the lower cellularity, the
scaffold sections showed a tissue-like organization with features
similar to that of the patient’s tumor. In particular the matrix
structure and the morphology of cancer cells with large and
polylobate nuclei (arrowhead in Fig. 1C) were maintained, as
reviewed by an experienced pathologist in sarcoma (Fig. 1C). This
architecture was completely lost in monolayer systems. Finally, 3D
scaffold culturing promoted cell-to-cell adhesion, resulting in
enhanced cell aggregation after recovery of primary cells from the
constructs (Fig. 1D).
Cancer cell enrichment and preservation of liposarcoma-
associated markers in the 3D tumor model
The presence of tumor cells in primary cultures was confirmed
by MDM2 in situ hybridization of paraffin-embedded scaffold
sections and of cytospin slides of monolayer cells. Culturing
within our 3D system conferred a selective advantage to
cancer cells with respect to their stromal counterpart which
resulted in a strong enrichment of dedifferentiated liposarcoma
cells from fibroblasts (Fig. 2A). The percentage of cells
harboring MDM2 amplification in monolayer cultures was
significantly lower than that of cells cultured on collagen-
Fig. 1. Characterization of the ex vivo 3D
tumor model. (A) Scanning electron
microscopy (SEM) analysis of collagen-
based scaffolds at different magnifications.
Images were taken with a FEI Nova
NanoSEM microscope. (B) Pictures of
collagen scaffolds pre- and post-
cellularization with primary liposarcoma
cells and hematoxylin & eosin staining of
paraffin-embedded sections of the scaffold
pre- and post-cellularization (C)
Hematoxylin & eosin staining of paraffin-
embedded sections of 3D scaffolds cultured
with primary liposarcoma cells and of the
histological specimen. Arrowheads indicate
tumor cells. (D) Inverted microscopy
pictures of 2D-cultured and 3D-recovered
liposarcoma cells.
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based scaffolds, i.e. <5% and >50%, respectively (Fig. 2B).
Furthermore, cells in our 3D model showed an induction of
specific biomarkers associated with liposarcoma pathogenesis,
e.g. β-catenin and E-cadherin, and aggressiveness, e.g.
ALDH1, MMP2, MMP9 and Slug. The expression of β-
catenin, MMP2, MMP9 and Slug was significantly higher in
3D-cultured cells compared to cells in monolayer cultures,
while E-cadherin levels were significantly reduced.
Conversely, ALDH1 expression was higher in monolayer
cultures than in the 3D model (Fig. 2C).
Efficacy of chemotherapy in 3D-enriched liposarcoma cells
We assessed the sensitivity of our primary liposarcoma culture to
the combination of epirubicin plus ifosfamide (standard
chemotherapy for DDLPS), and also to trabectedin. Drugs were
tested on 3D-enriched cancer cells to assess sensitivity in a
tumor-representative population. Both tested schedules showed a
strong antiproliferative effect on DDLPS cells, with survival
percentages significantly lower than in untreated controls for
both the combination of epirubicin plus ifosfamide and
trabectedin alone (48% and 53%, respectively) (Fig. 3A). Drug
efficacy was confirmed by TUNEL assessment of apoptosis. The
number of apoptotic cells counted in the presence of either
treatment was significantly higher than that of untreated controls
(Fig. 3B). TUNEL positivity resulted higher in cells treated with
epirubicin plus ifosfamide compared to trabectedin alone
(Fig. 3B).
Engraftment and invasive ability of primary cells in the
zebrafish model
Given the low amount of cells available, we injected cells
resuspended in Matrigel, in order to favor the engraftment whilst
maintaining cell-to-cell contact. We successfully engrafted cells
into Tg(kdrl:mCherry) zebrafish using Matrigel as a vehicle and
implanting the cells into the embryonic heart cavity at 2 day post-
fertilization (dpf ). The implantation allowed cells (asterisk in
Fig. 4A) to be contained within the embryonic heart cavity whilst
retaining close proximity to anatomical vasculature and the
epithelium surrounding the yolk sac, permitting adhesion and
potentially active migration of cancer cells (Fig. 4A). The zebrafish
model, used primarily to stabilize the near-patient material in vivo
and to assess the invasive capacity of cancer cells, permitted the
tracking of single-cell movement across tissues of the developing
zebrafish embryos. Cells were shown to be scattered throughout the
implantation area (asterisks in Fig. 4B) at 4 day post-implantation
(dpi), confirming local invasiveness ability (Fig. 4B). The cells
recapitulated their polarized phenotype in vivo and remained visible
with CFSE labeling for the entire duration of the in vivo
experiments. The implanted cells survived in the zebrafish
embryos over time: the average number of foci of engrafted cells
per embryo was about 10.5 at 1 dpi and about 6.5 at 4 dpi (Fig. 4C).
In order to detect the preferential site of cell engraftment, the imaged
embryos were divided into three anatomical regions (head, body and
tail, Fig. S1) and the number of foci of engrafted cells in each region
at every time point were counted. As shown by the graph in Fig. 4D,
Fig. 2. Liposarcomacells enrich in the 3D tumormodel. (A) Fluorescence in situ hybridization forMDM2 amplification in 2D and 3D cultured liposarcoma cells.
Arrowheads represent the cells with MDM2 amplification. (B) Percentages of cells positive for MDM2 amplification in 2D and 3D cultures. Data are mean±s.d.
(n=3). (C) Heatmap representation and relative quantitation values of Slug (SLUG), beta-catenin (BCAT), matrix metalloproteinase 2 (MMP2), matrix
metalloproteinase 9 (MMP9) and aldehyde dehydrogenase 1 (ALDH) in 2D and 3D cultured primary liposarcoma cells and in the patient’s original tumor
specimen. Data are mean±s.d. (n=3). Unpaired t-test between 2D and 3D relative quantitation values, *P=0.0063 for SLUG, *P=0.092 for CAD, *P=0.0114 for
MMP9, *P=0.0026 for ALDH.
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the cells engrafted preferentially in the body region of the embryos,
and some foci engrafted in the head region, while cells in the tail
region tended not to survive at later time points.
DISCUSSION
In the present study we developed a highly translational approach
that took advantage of both in vitro 3D cultures and the in vivo
zebrafish model to study a patient-derived surgical specimen. This
strategy allowed for an effective molecular and functional
characterization of the near-patient primary culture. In recent
years, increasing attention has been paid to 3D culture systems
which enable cells to retain more in vivo-like biological behavior
than cultures grown in bidimensional substrates (Fischbach et al.,
2007). Whilst this feature is extremely useful for the culture of
established cell lines, it becomes fundamental when dealing with
patient-derived material which has not undergone the process of
adaptation to in vitro culturing. In contrast to monolayer systems,
our 3Dmodel exhibited a high degree of morphological similarity to
the patient’s tumor histology, suggesting that it could more
faithfully replicate the clinical scenario than standard culture
methods. Moreover, on 2D supports, cancer cells may be
overtaken by infiltrating stroma, e.g. cancer-associated fibroblasts
Fig. 3. Sensitivity of primary
liposarcoma cells to
chemotherapy drugs. (A) Survival
percentages of primary liposarcoma
cells not treated (CTR), treated with
epirubicin plus ifosfamide (EPI IFO)
or treated with trabectedin (TRABE).
Data are mean±s.d. (n=5). Unpaired
t-test. (B) TUNEL staining of primary
liposarcoma cells CTR, EPI IFO,
TRABE (green, TUNEL positive
cells; blue, nuclei stained with DAPI).
Images were analyzed with Image J
software (NIH Image, Bethesda,
MD). Percentages of TUNEL-positive
primary liposarcoma cells not treated,
treated with epirubicin plus
ifosfamide or treated with
trabectedin. Data are mean±s.d.
(n=5).
Fig. 4. Representative stereomicrograph images
of primary liposarcoma cells (green, CFSE)
injected into 2 dpf Tg(Kdrl:mCherry) zebrafish
embryos. Images taken at (A) 1 dpi and (B) 4 dpi.
White circles indicate the area zoomed in the close-
ups; white asterisks indicate the injected cells
(A) and the invading cells (B). The number of
engrafted foci per embryo is reported. Quantification
of total number of engrafted foci at 1 and 4 dpi
(C) (mean±s.d., n=4) and quantification of engrafted
foci in the three different anatomical regions of the
zebrafish embryos (D) (mean±s.d., n=3). White, tail
region; gray, body region; black, head region. At
4 dpi, we detected that liposarcoma-derived cells
survived in vivo and spread from the injection site. Of
note, injected embryos showed an aspecific CFSE
signal in the gastrointestinal trait of the embryos, at
the initial timepoint of the experiment (1 dpi), due to
dye leakage. This aspecific signal faded out at the
later timepoint, as visible in the pictures of 4 dpi
embryos.
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and fibroblast-like cells, requiring the use of selective media,
specific growth factors or ad hoc culturing techniques. Conversely,
our 3D system provided the necessary stimuli to enrich the
liposarcoma cell fraction over the stromal counterpart. More
importantly, 2D culturing of near-patient material induces an
in vitro adaptation process that may end up in cancer cells losing
their characteristic markers (Fan et al., 2012; Talasila et al., 2013). In
our study, 3D-cultured cancer cells preserved both MDM2
amplification and gene expression associated with liposarcoma
pathogenesis and aggressiveness (Benassi et al., 2001; Gogou et al.,
2012; Guo et al., 2008; Pazzaglia et al., 2004; Stratford et al., 2011;
Somarelli et al., 2016), suggesting that this in vitro model could
facilitate the identification of disease-specific biomarkers. We then
used 3D-enriched cancer cells to carry out drug activity screening.
Both treatment schedules exerted a cytotoxic effect on the
liposarcoma culture. The patient showed no evidence of disease
after undergoing three cycles of treatment with the epirubicin plus
ifosfamide combination. However, a longer follow up is needed to
see whether a correlation exists between the response of the patient
and the in vitro data. There is also a possibility that the disease
eradication was a result of the surgical treatment. Although there is
still no acknowledged indication for the use of trabectedin in this
liposarcoma subtype, clinical trials on the drug are currently
ongoing. Our work also provides a rationale for further exploring
the effects of trabectedin in DDLPS as its anti-tumoral activity was
comparable with that of epirubicin plus ifosfamide (Demetri et al.,
2009; Petek et al., 2015). While the cytotoxicity was similar,
epirubicin plus ifosfamide induced a higher apoptotic cell death
compared to trabectedin, which is also known to exert its effect by
the arrest of the cell cycle (D’Incalci, 2013).
These translational models could also be used to study drug
resistance mechanisms, in particular to understand why the majority
of DDLPS show limited responsiveness to chemotherapy. Although
surgical resection of DDLPS usually involves the excision of a
substantial amount of tissue, the material excised from our patient
was scant as it was a recurrent lesion. Inoculation of primary cells
into mouse models was therefore not feasible and the experimental
approach had to be scaled down to accommodate the limited
material available. In such settings, the zebrafish model, requiring
only a small number of cells per assay, becomes a valuable resource
as it allows for the evaluation of complex cancer-related features
such as cell migration, extravasation, invasion and metastasis
formation (He et al., 2012; Pickart and Klee, 2014; Stoletov and
Klemke, 2008). The model also has at least two other important
advantages: the transparent body of the embryos permits an easy
follow up of injected cells, and clear results can be obtained after
only a few days (Konantz et al., 2012). For these reasons we
functionally assayed primary cells in zebrafish, successfully
engrafting for the first time liposarcoma cells from a near-patient
culture into this in vivo model. The cells were retained until the end
of experiment at 4 dpi and showed progressive migration from the
site of implantation. This finding is in line with our in vitro
functional characterization of these cells which showed extensive
extracellular matrix (ECM) remodeling abilities and MMP
upregulation when the cells were seeded on collagen scaffolds.
This migratory phenotype has been well documented in zebrafish
xenografts of malignant cells and is not recapitulated by healthy or
non-transformed, fibrotic-derived tissues (Barriuso et al., 2015). In
addition, the previously mentioned studies (Bansal et al., 2014;
Barriuso et al., 2015; Bentley et al., 2015; Marques et al., 2009;
Orlova et al., 2014; Pruvot et al., 2011; Rampazzo et al., 2013)
reported that cells derived from healthy tissues and from non-
invasive malignant cells are not retained in the zebrafish and tend to
disappear a few days after transplantation. Moreover, the in vivo
behavior of these cells closely resembled that of the local invasive
phenotype in the patient, as reported in the pathologist’s referral of
the excised tumor.
Although this work is limited by the inclusion of only a single
primary culture, we provided proof of concept that the 3D and the
zebrafish models could be used in translational research studies for
biomolecular analyses, drug screenings and tumor invasiveness
assays of patient-derived material.
Optimization and validation of these models through the
culturing and xenografting of additional primary specimens is
required, especially in order to explore the usefulness of these
systems to study different tumor subtypes maintaining their
heterogeneity. Finally, the use of the zebrafish may be exploited
to compare the in vivo behavior of primary cells cultured in 3D or in
monolayer systems, and to test the efficacy of drugs on primary cells
engrafted in vivo.
MATERIALS AND METHODS
Collagen scaffold synthesis and characterization
All chemicals were purchased from Sigma-Aldrich (St. Louis, MO, USA).
The collagen scaffolds were synthesized as follows (Minardi et al., 2014): an
acidic suspension of 1 wt% bovine type I collagen was prepared and
precipitated to pH 5.5. The material was crosslinked with 1wt% 1,4-
butanediol diglycidyl ether (BDDGE) to stabilize the collagen matrix and
control porosity. The final monolithic scaffold was generated through a
freeze-drying process. An established freezing and heating ramp yielded
scaffolds with optimal levels of pore interconnectivity, orientation and
porosity. All scaffolds were sterilized by immersion in 70% ethanol for 1 h,
followed by three washes in sterile Dulbecco phosphate buffered saline
(DPBS) (Life Technologies, Carlsbad, CA). The scaffolds were imaged by
Scanning ElectronMicroscopy (SEM) as follows. The samples werewashed
three times with 0.1 M sodium cacodylate buffer pH 7.4, fixed in 2.5%
glutaraldehyde in 0.1 M sodium cacodylate buffer pH 7.4 for 2 h at 4°C and
washed again in 0.1 M sodium cacodylate buffer pH 7.4. Samples were then
dehydrated in a graded series of ethanol for 10 min each, dried in a desiccator
overnight and sputter-coated with platinum. Images were acquired with
Nova NanoSEM scanning electron microscope (FEI, Hillsboro, OR).
Patient history
A 53-year-old man with an abdominal liposarcoma previously operated on
in another hospital was seen at our institute. A contrast-enhanced chest-
abdomen CT scan revealed the presence of three residual tumor nodules of
about 12, 15 and 21 mm in diameter in the retroperitoneal pelvic space, with
infiltration of muscular fascia and perilesional tissue. The patient refused
chemotherapy before surgery and underwent tumor excision with
radiofrequency dissector. Histological analysis of the surgical specimen
(10.5×7×3 cm), composed of four contiguous nodular lesions of 3.5, 3, 1.2
and 0.5 cm, revealed dedifferentiated grade 3 liposarcoma according to the
French Federation of Cancer Centers Sarcoma Group (FNCCL) grading
system. Large areas of necrosis and numerous mitoses were present. Cancer
cells were positive for MDM2 amplification and desmin, with focal actin
expression, and negative for miogenin. The patient underwent three cycles
of adjuvant chemotherapy with epirubicin plus ifosfamide and inMay 2016,
9 months after the end of treatment, radiological evaluation showed no
evidence of disease.
Isolation of primary liposarcoma cells
Tumor specimens were obtained from a surgically resected retroperitoneal
lesion. The surgical material was analyzed and selected by a pathologist
experienced in sarcoma and processed within 3 h of removal. The specimen
was washed twice in sterile phosphate buffered saline (PBS) supplemented
with 10% penicillin/streptomycin and disaggregated into 1-2 mm3 pieces
with sterile surgical blades. The fragments obtained were incubated with
2 mg/ml of collagenase type I (Millipore Corporation, Billerica, MA) at
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37°C under stirring conditions. The enzymatic digestion was stopped after
2 h by adding DMEM supplemented with 10% fetal bovine serum, 1%
glutamine and 10% penicillin/streptomycin. The cell suspension was then
filtered with 100 µm sterile mesh filters (CellTrics, Partec, Münster,
Germany). Cells were counted and seeded in standard monolayer cultures at
a density of 80,000 cells/cm2 or in collagen-based scaffolds at a density of
500,000 cells/57 mm3. All cells were maintained in complete DMEM
medium at 37°C in a 5% CO2 atmosphere. All downstream analyses were
performed after 3 weeks of culture in either setting.
The study was reviewed and approved by the Local Ethics Committee and
performed in accordance with the principles of Good Clinical Practice and
the Helsinki declaration. The patient provided written informed consent to
take part in the study.
Immunohistochemical analysis
The 3D constructs were fixed in 10% neutral buffered formalin for 24 h and
dehydrated in a graded series of ethanol. Samples were then embedded in
paraffin, sliced with a rotating microtome (Leica Biosystems) at a thickness
of 5 µM and mounted on Superfrost Plus microslides (Thermo Fisher
Scientific, Waltman, MA). Hematoxylin and eosin (H&E) staining was
performed to evaluate scaffold architecture and cell morphology and
distribution. MDM2 amplification was detected by FISH (Vysis MDM-2/
CEP12 dual color FISH Probe Kit) according to the manufacturer’s
instructions. For monolayer cultures, 100,000 cells were cytospinned onto
glass slides and MDM2 amplification evaluated by FISH.
Cell recovery from scaffolds and downstream characterization
Cells were recovered from the 3D constructs by disaggregating the scaffolds
into 1-2 mm3 pieces with sterile surgical blades followed by enzymatic
digestion in 2 mg/ml of collagenase type I (Millipore Corporation) for 1 h at
37°C under stirring conditions. The cell suspension was then filtered with
100 µm sterile mesh filters (CellTrics, Partec).
Quantitative real-time reverse transcriptional-PCR (qRT-PCR)
For RNA extraction, cell-seeded scaffolds were fragmented into small
pieces and 2D culture cells were collected by tripsinization. Total mRNA
was isolated using TRIzol Reagent (Invitrogen) following the
manufacturer’s instructions. Five hundred nanograms of RNA were
reverse-transcribed using the iScript cDNA Synthesis Kit (BioRad,
Hercules, CA). Real-Time PCR was performed on the 7500 Real-Time
PCR System using the TaqMan gene expression assay mix (Applied
Biosystems, Foster City, CA). Amplification was performed in a final
volume of 20 µl containing 2× Gene expression master Mix, 2 µl of cDNA
in a total volume of 20 µl. The stably expressed endogenous β-actin, β-2-
microglobulin, HPRT and 18S rRNA were used as reference genes. The
following markers were analyzed: ALDH1A1, CDH1, CTNNB1, MMP2,
MMP9, SNAI2, GAPDH. The amount of transcripts was normalized to the
endogenous reference genes and expressed as n-fold mRNA levels relative
to a calibrator using a comparative threshold cycle (Ct) value method
(ΔΔCt). RNA extracted from the tumor sample was used as calibrator.
Drug testing
For drug assessment, 3D-recovered cells were seeded in 96-well plates at a
density of 80,000 cells/cm2. Cells were allowed to recover for 3 days and
then treated with the following schedules: epirubicin 2 µg/ml plus
ifosfamide 100 µM or trabectedin 17 ng/ml, according to the plasma peak
levels of each compound (Highley et al., 2015). Medium was changed after
48 h and replaced with fresh complete DMEM. Survival percentages were
assessed after a 24 h washout byMMTassay (Sigma-Aldrich) in accordance
with the manufacturer’s instructions.
TUNEL assay
Fragmented DNA generated in response to apoptotic signals was detected by
the terminal deoxynucleotidyl transferase (TdT) nick end labeling (TUNEL)
assay. After each treatment schedule, cells werewashed twicewith PBS, fixed
by incubation in 1% formaldehyde on ice for 15 min and in 70% ice cold
ethanol for 1 h. Cells were then washed twice in PBS, permeabilized in 0.1%
Triton-X100 for 5 min and incubated in 50 µl of solution containing TdT and
FITC conjugated dUTP deoxynucleotides 1:1 (Roche Diagnostic GmbH,
Mannheim, Germany) in a humidified atmosphere for 90 min at 37°C in the
dark. Nuclei were counterstained with ProLong Gold antifade reagent with
DAPI (Invitrogen, Life Technologies) and the samples were analyzed by
inverted fluorescence microscopy.
In vivo experiments with the zebrafish model
Zebrafish maintenance and cancer cell engraftment
Zebrafish and embryos were raised, staged and maintained according to
standard procedures in compliance with local animal welfare regulations
and the EU Animal Protection Directive 2010/63/EU. The transgenic line
Tg(Kdrl:mCherry) was used for this study and was kindly provided by
Prof. Schulte-Merker, Institute for Cardiovascular Organogenesis and
Regeneration, Faculty of Medicine, Westfälische Wilhelms-Universität
Münster (WWU). 0.2 mM of N-phenylthiourea (PTU; Sigma) was used to
prevent pigment formation from 1 day post-fertilization (dpf) onward.
Embryo preparation and tumor cell implantation
After 3 weeks of monolayer culture, liposarcoma cells were labeled with
CellTrace™ CFSE Cell Proliferation Kit (Life Technologies) according to
the manufacturer’s instructions, with a final dye concentration of 5 µM. The
labeled cell suspension was further re-suspended in 3 mg/ml of growth
factor-reduced Matrigel™ (BD Biosciences, Franklin Lakes, NJ, USA)
diluted in ice cold sterile DPBS (Gibco, Life Technologies) and loaded into
borosilicate glass capillary needles (1 mm outer diameter×0.78 mm inner
diameter; Harvard Apparatus) within 3 h of cell harvest, to a final
concentration of 2.5×105 cells/µl. Two-day-old (2 dpf) zebrafish embryos
were anesthetized with 0.003% tricaine (Sigma) and positioned on a 10 cm
Petri dish coated with 1% agarose dissolved in eggwater (demineralized
water containing 60 μg/ml of seasalt). 50-400 manually counted cells were
injected in the embryonic heart cavity using a Pneumatic Pico pump and a
micromanipulator (WPI), and 100 embryos were implanted with cancer
cells. After implantation with cancer cells, the zebrafish embryos (including
non-implanted controls) were maintained at 34°C as a compromise between
the optimal temperature requirements for fish and mammalian cells (Haldi
et al., 2006). Fluorescent image acquisition was performed using a Leica
MZ16FA stereo microscope (Leica Microsystems GmbH, Wetzlar,
Germany). Up to 400 implantations were manually achieved per hour,
with survival rates of >80% up to the fourth day post-implantation (dpi).
Images were further analysed with the software ImageJ (Rasband, W.S.,
ImageJ, U. S. National Institutes of Health, Bethesda, Maryland, USA,
http://imagej.nih.gov/ij/, 1997-2016).
Statistical analysis
At least three independent biological replicates were performed for each
experiment. Data are presented as mean±standard deviation (s.d.), or
mean±standard error (s.e.), as stated, with n indicating the number of
replicates. For in vitro and in vivo data, differences between groups were
assessed by a two-tailed Student’s t-test and accepted as significant at
P<0.05.
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